Until recently, receiving an Alzheimer’s diagnosis often required an expensive brain scan or invasive procedure. The introduction of the Alzheimer’s Screening and Prevention (ASAP) Act aims to change that by expanding access to innovative diagnostic tools that could make screening more affordable and accessible.

As the ASAP Act continues to gain bipartisan support, the Alliance remains committed to advancing innovations in Alzheimer’s care and amplifying the voices of advocates working to improve access to early detection.

Joining us to discuss the ASAP Act and its potential to remove barriers to care is patient advocate and Alliance for Aging Research Board Member Jay Reinstein.